CD83 and bone metastasis: Six proteins (CSF-1, CCL4, CCL3, CD83, IL-12, and CD244) and three clinical characteristics (LDH levels, bone metastasis status, and liver metastasis status) were incorporated into the predictive model (Fig. 6b).